|
Sunesis Pharmaceuticals Inc., up 22 cents at $2.26 A Canaccord analyst initiated coverage of the biopharmaceutical company with a "Buy" rating on the potential of a cancer treatment. OmniVision Technologies Inc., up $1.33 at $17.16 A Baird analyst upgraded the image sensor maker's stock saying he thinks the sensor may be used in Apple's new iPad.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor